Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.
2.
3.

Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia.

Muscedere JG, Day A, Heyland DK.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S120-5. doi: 10.1086/653060. Review.

4.

Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences.

Weiss E, Dahmani S, Bert F, Janny S, Sommacale D, Dondero F, Francoz C, Belghiti J, Mantz J, Paugam-Burtz C.

Liver Transpl. 2010 Oct;16(10):1178-85. doi: 10.1002/lt.22132.

5.

Use of severity scoring and stratification factors in clinical trials of hospital-acquired and ventilator-associated pneumonia.

Napolitano LM.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S67-80. doi: 10.1086/653052. Review. Erratum in: Clin Infect Dis. 2010 Nov 1;51(9):1114.

6.

Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: risk factors and impact on outcomes.

Piskin N, Aydemir H, Oztoprak N, Akduman D, Comert F, Kokturk F, Celebi G.

BMC Infect Dis. 2012 Oct 24;12:268. doi: 10.1186/1471-2334-12-268.

8.

Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective.

Barriere SL.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S4-9. doi: 10.1086/653033. Review. Erratum in: Clin Infect Dis. 2010 Nov 1;51(9):1114.

9.

Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.

Sorbello A, Komo S, Valappil T, Nambiar S.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S36-41. doi: 10.1086/653038. Review.

10.

High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.

Chung DR, Song JH, Kim SH, Thamlikitkul V, Huang SG, Wang H, So TM, Yasin RM, Hsueh PR, Carlos CC, Hsu LY, Buntaran L, Lalitha MK, Kim MJ, Choi JY, Kim SI, Ko KS, Kang CI, Peck KR; Asian Network for Surveillance of Resistant Pathogens Study Group.

Am J Respir Crit Care Med. 2011 Dec 15;184(12):1409-17. doi: 10.1164/rccm.201102-0349OC. Epub 2011 Sep 15.

PMID:
21920919
11.

Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box.

Craven DE, Hjalmarson KI.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S59-66. doi: 10.1086/653051. Review. Erratum in: Clin Infect Dis. 2010 Nov 1;51(9):1114.

12.

Surrogate markers and microbiologic end points.

Wunderink RG.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S126-30. doi: 10.1086/653061. Review.

13.

What is ventilator-associated pneumonia and why is it important?

Kollef MH.

Respir Care. 2005 Jun;50(6):714-21; discussion 721-4.

14.

Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines.

File TM Jr.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S42-7. doi: 10.1086/653048. Review. Erratum in: Clin Infect Dis. 2010 Nov 1;51(9):1114.

15.

Other therapeutic modalities and practices: implications for clinical trials of hospital-acquired or ventilator-associated pneumonia.

Chastre J, Luyt CE.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S54-8. doi: 10.1086/653050. Review. Erratum in: Clin Infect Dis. 2010 Nov 1;51(9):1114.

16.
17.

Antibiotic resistance in nosocomial respiratory infections.

Denys GA, Relich RF.

Clin Lab Med. 2014 Jun;34(2):257-70. doi: 10.1016/j.cll.2014.02.004. Epub 2014 Apr 13. Review.

PMID:
24856527
18.

Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia.

Torres A, Ferrer M, Badia JR.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S48-53. doi: 10.1086/653049. Review. Erratum in: Clin Infect Dis. 2010 Nov 1;51(9):1114.

19.
20.

Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.

Jantausch BA, Deville J, Adler S, Morfin MR, Lopez P, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.

Pediatr Infect Dis J. 2003 Sep;22(9 Suppl):S164-71.

PMID:
14520142
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk